Evidence map›Paper›PMID 24777096›Full record

ArticleAntimicrobial agents and chemotherapy2014

Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Jesús Oteo, Juan José González-López, Adriana Ortega, J Natalia Quintero-Zárate, Germán Bou, Emilia Cercenado, María Carmen Conejo, Luis Martínez-Martínez, Ferran Navarro, Antonio Oliver and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Increased Prevalence of Multidrug-ResistantLife (Basel, Switzerland) · 2026
    Article
  3. Community Emergence of Cefixime-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prevalence and characteristics of ST131 clone among unselected clinicalAntimicrobial resistance and infection control · 2017
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Jesús OteoLaboratorio de Antibióticos, Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain jesus.oteo@isciii.es.
Juan José González-LópezServei de Microbiologia, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Adriana OrtegaLaboratorio de Antibióticos, Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
J Natalia Quintero-ZárateServei de Microbiologia, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Germán BouServicio de Microbiología-INIBIC, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Emilia CercenadoServicio de Microbiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
María Carmen ConejoDepartamento de Microbiología, Facultad de Medicina, Sevilla, Spain.
Luis Martínez-MartínezServicio de Microbiología, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.
Ferran NavarroServei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Antonio OliverServicio de Microbiología, Hospital Son Espases, Palma de Mallorca, Spain.
Rosa M BartoloméServei de Microbiologia, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
José CamposLaboratorio de Antibióticos, Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Spanish Network for Research in Infectious Diseases (REIPI)
Universitat Autònoma de Barcelona · ESCentro Nacional de Microbiologia · ESComplexo Hospitalario Universitario A Coruña · ESFundación Marques de Valdecilla · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario Son Espases · ESInstituto de Salud Carlos III · ESUniversidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a previous prospective multicenter study in Spain, we found that OXA-1 and inhibitor-resistant TEM (IRT) β-lactamases constitute the most common plasmid-borne mechanisms of genuine amoxicillin-clavulanate (AMC) resistance in Escherichia coli. In the present study, we investigated the population structure and virulence traits of clinical AMC-resistant E. coli strains expressing OXA-1 or IRT and compared these traits to those in a control group of clinical AMC-susceptible E. coli isolates. All OXA-1-producing (n = 67) and IRT-producing (n = 45) isolates were matched by geographical and temporal origin to the AMC-susceptible control set (n = 56). We performed multilocus sequence typing and phylogenetic group characterization for each isolate and then studied the isolates for the presence of 49 virulence factors (VFs) by PCR and sequencing. The most prevalent clone detected was distinct for each group: group C isolates of sequence type (ST) 88 (C/ST88) were the most common in OXA-1 producers, B2/ST131 isolates were the most common in IRT producers, and B2/ST73 isolates were the most common in AMC-susceptible isolates. The median numbers of isolates per ST were 3.72 in OXA-1 producers, 2.04 in IRT producers, and 1.69 in AMC-susceptible isolates; the proportions of STs represented by one unique isolate in each group were 19.4%, 31.1%, and 48.2%, respectively. The sum of all VFs detected, calculated as a virulence score, was significantly higher in AMC-susceptible isolates than OXA-1 and IRT producers (means, 12.5 versus 8.3 and 8.2, respectively). Our findings suggest that IRT- and OXA-1-producing E. coli isolates resistant to AMC have a different and less diverse population structure than AMC-susceptible clinical E. coli isolates. The AMC-susceptible population also contains more VFs than AMC-resistant isolates.

Indexed as

Amoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsHumansMolecular EpidemiologyMultilocus Sequence TypingPhylogenyVirulenceVirulence FactorsAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-lactamase OXA-2beta-Lactamasesbeta-lactamase TEM-1Virulence Factors

Identifiers

PMID24777096
PMCPMC4068566
OpenAlexW2097529484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.